BK

Bemena Kalathingal Thodi

Active Director Director DIN 09784578
DIN 09784578 First appointment Nov 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Bemena Kalathingal Thodi

Data last updated:

Bemena Kalathingal Thodi is a Director at Nucleosome Health Private Limited (since 2022). The company operates in Healthcare.

DIN 09784578
Primary Designation Director
Industry Healthcare
First Appointment 09 Nov 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nucleosome Health Private Limited U24299KL2022PTC078733
Director09 Nov 20222022Active

Board colleagues of Bemena Kalathingal Thodi

NameDINCompanyDesignation
Tharayil Aboobacker09784577Nucleosome Health Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nucleosome Health Private Limited
Premium access

Shareholding and investment profile for Bemena Kalathingal Thodi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bemena Kalathingal Thodi

Bemena Kalathingal Thodi currently holds 1 directorship: Nucleosome Health Private Limited (Director, since 09 Nov 2022).

Bemena Kalathingal Thodi was first appointed on 09 Nov 2022 as Director at Nucleosome Health Private Limited.

The current boards of Bemena Kalathingal Thodi's companies include Tharayil Aboobacker (Nucleosome Health Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available